NORML is seeking formal participant status in the DEA's upcoming administrative hearing on cannabis rescheduling, arguing the consumer perspective is cruc…
Discover how the UK's medical cannabis access has significantly expanded since 2018, largely through private clinics and telehealth. This analysis details…
Australian medicinal cannabis prescriptions have quadrupled, with many for mental health. This article explores the regulatory landscape, current evidence…
Georgia's "Putting Georgia Patients First Act" expands medical cannabis access, adding conditions like lupus and Crohn's disease, and permitting inhalatio…
ASX medicinal cannabis stocks are increasingly prioritising pharmacy channels, export frameworks, and healthcare distribution to drive growth. Understand…
A former notary involved in Nebraska medical cannabis petitions is appealing 24 criminal convictions for official misconduct and false statements, raising…
The White House asserts new legal authority to regulate intoxicating hemp products like delta-8 THC. Learn about the 2026 Farm Bill's impact and DEA regis…
Nebraska Congressman Mike Flood addressed constituent concerns regarding medical cannabis enforcement and federal rescheduling at a recent town hall. Lear…
Nebraska, Indiana, and Louisiana, alongside prohibitionist groups, have filed petitions challenging the federal medical cannabis rescheduling in the U.S.…
Rhode Island Governor Dan McKee has nominated Michelle Reddish to chair the state's Cannabis Control Commission. This appointment comes amidst a federal h…